Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-05-20
1990-10-23
Rosen, Sam
Drug, bio-affecting and body treating compositions
Lymphokine
435238, A61K 3912
Patent
active
049650696
ABSTRACT:
Novel and improved methods for diagnosis, prognosis, prophylaxis and therapy of viral infections are described. The novel methods employ a virus, viral antigen or fragment thereof in which "perturbation" of an oligosaccharide moiety renders the virus, viral antigen or fragment thereof more specifically recognizable or reactive with neutralizing antibody. As described, "perturbation" of an oligosaccharide moiety encompasses a variety of modifications such has one that (1) alters the chemical or physical structure of a carbohydrate residue that is naturally present; (2) that removes, wholly or in part, a carbohydrate residue; and/or (3) that prevents or alters addition of a carbohydrate residue. A variety of different methods for oligosaccharide "perturbation" are also described. In particular, the carbohydrate residue is altered by an oxidizing agent.
REFERENCES:
patent: 3326767 (1967-06-01), Holper et al.
patent: 3839555 (1974-10-01), Billiau et al.
patent: 4196265 (1980-04-01), Koprowski et al.
patent: 4217338 (1980-08-01), Quash
patent: 4355102 (1982-10-01), Quash
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4367309 (1983-01-01), Kondo et al.
patent: 4419444 (1983-12-01), Quash
patent: 4634666 (1987-01-01), Engleman et al.
Davis et al., Microbiology, Fourth Edition, J. B. Lippincott Company, Philadelphia, 1990, p. 890.
Prince et al, Journ. Virol., 57, 721-728, 1986.
Murphy et al., Journ. Clin, Microbiol., 24, 197-202, 1986.
Schlesinger, Virology Monograms, 16, Springer-Verlag, New York, 1977, pp. 1-132.
Means et al., Chemical Modification of Proteins, Holden Day Inc., 1971, pp. 126-127.
Johnson et al., Journ. Biol., Chem., 234, 4022-4026, 1979.
Hallum et al., Virology, 12, 283-308, 1960.
Barrett, Textbook of Immunology, Third Edition, The C. V. Mosby Company, Saint Louis, 1978. pp. 294-300.
Gerschenfeld, American Journ. Pharmacy, 135, 278-287, 1963.
Dresman et al., Virology, 69, 700-709, 1976.
Berman et al., 1985, Trends in Biochem. 3:51-53.
Finegold et al., 1978, in Baley and Scott's Diagnostic Microbiology, 5th ed., The C. V. Mosby Company, pp. 272-278.
Glorioso et al., 1983, Virol. 126:1-18.
Hagenarrs et al., 1983, J. Virol. Meth. 6:233-239.
Krech et al., 1971, Z. Immun. Forsch. Bd. 141:S411-429.
Lee et al., 1984, Proc. Nat'l Acad. Sci. USA 81:3856-3860.
Peake et al., 1982, J. Virol. 42(2):678-690.
McKearn Thomas J.
Quash Gerard A.
Ripoll Jean P.
Rodwell John D.
Rosen Sam
Saunders David A.
LandOfFree
Oxidized viruses or viral antigens and utilization for diagnosti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxidized viruses or viral antigens and utilization for diagnosti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidized viruses or viral antigens and utilization for diagnosti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-765515